Alopecia Areata in the Autoimmune Spectrum: Comorbidities, Screening, and Diagnostic Pitfalls

The speaker reviewed how alopecia areata fits into the autoimmune spectrum, emphasizing that patients commonly ask about their risk of developing additional autoimmune diseases and that this concern is supported by evidence. A large meta-analysis showed increased associations with several inflammatory and autoimmune conditions, including atopic dermatitis, chronic urticaria, psoriasis, vitiligo, inflammatory bowel disease, celiac disease, systemic lupus erythematosus, and autoimmune thyroid disease. The speaker noted that overlapping immune pathways can also mean one treatment may improve more than one disease, citing examples such as tofacitinib improving both psoriasis and alopecia universalis, and dupilumab leading to hair regrowth in a child with atopic dermatitis. There are no formal universal screening guidelines for alopecia areata, so broad indiscriminate testing is not recommended; instead, screening should be guided by history, review of systems, and skin exam. Suggested tests included celiac serologies or fecal calprotectin for GI symptoms, RF/CCP for inflammatory arthritis, ANA when lupus is clinically suspected, TSH/T4 and TPO antibodies for fatigue or thyroid concerns, CBC/CMP, and A1C in appropriate patients. The speaker cautioned that ANA is often overordered and is frequently positive in healthy individuals or thyroid disease, and a positive result alone does not diagnose SLE. The second half focused on diagnostic pitfalls, showing how alopecia areata can mimic or be mistaken for discoid lupus, lichen planopilaris, morphea/eosinophilic fasciitis overlap, or early Parry-Romberg syndrome, and vice versa. Key clues favoring alternative diagnoses included erythema, scale, dyspigmentation, scarring, follicular plugging, atrophy, and facial or systemic involvement. Biopsy and trichoscopy can be helpful, but must be interpreted alongside the clinical exam. Overall, the main message was that alopecia areata often coexists with other autoimmune disease and can be confused with scarring and connective tissue disorders, so clinicians should screen thoughtfully and keep a broad differential.